This inventor holds 22 USPTO granted patents and 1 published patent application, plus 1 CIPO patent, primarily in Pharmaceutical Aerosols. Top assignee: Glaxo Group Limited. Active years: 1989-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Dry Drayton, GB (1989)
- Ware, GB (1997 - 2005)
- Hertsfordshire, GB (2005 - 2009)
Company Filing History:
Years Active: 1989-2009
Areas of Expertise:
As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with the requested article about inventor David Andrew Wyatt.
Title: The Innovative Works of David Andrew Wyatt
Introduction: David Andrew Wyatt, a prolific inventor hailing from Ware, GB, has made significant contributions in the field of pharmaceutical aerosol formulations for the treatment of respiratory disorders. With an impressive portfolio of 22 patents, Wyatt's innovative creations have revolutionized drug delivery mechanisms.
Latest Patents: Among his recent patents include groundbreaking inventions such as "Medicaments" and "Aerosol formulation containing particulate formoterol, propellant, and polar cosolvent." These patented formulations introduce novel approaches to administering medicaments through inhalation, offering effective treatments for respiratory ailments.
Career Highlights: David Andrew Wyatt is a key figure at Glaxo Group Limited, where his expertise and ingenuity have played a pivotal role in advancing the pharmaceutical industry. His 22 patents stand as a testament to his dedication to improving patient care and revolutionizing drug delivery technologies.
Collaborations: Wyatt has collaborated closely with esteemed colleagues such as Rachel Ann Akehurst and Anthony James Taylor. Together, they have combined their expertise to enhance the efficacy and safety of pharmaceutical aerosol formulations, paving the way for innovative treatment options in respiratory medicine.
Conclusion: In conclusion, David Andrew Wyatt's trailblazing work in the field of pharmaceutical aerosol formulations underscores his commitment to innovation and improving healthcare outcomes. His contributions continue to inspire advancements in drug delivery systems, benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile